These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24503249)

  • 1. Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes.
    Pal S; Bi Y; Macyszyn L; Showe LC; O'Rourke DM; Davuluri RV
    Nucleic Acids Res; 2014 Apr; 42(8):e64. PubMed ID: 24503249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of data discretization methods to derive platform independent isoform expression signatures for multi-class tumor subtyping.
    Jung S; Bi Y; Davuluri RV
    BMC Genomics; 2015; 16 Suppl 11(Suppl 11):S3. PubMed ID: 26576613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.
    Zhang JX; Zhang J; Yan W; Wang YY; Han L; Yue X; Liu N; You YP; Jiang T; Pu PY; Kang CS
    Neuro Oncol; 2013 Mar; 15(3):279-89. PubMed ID: 23295773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
    Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
    Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of robust discriminant equations for assessing subtypes of glioblastoma biopsies.
    Castells X; Acebes JJ; Majós C; Boluda S; Julià-Sapé M; Candiota AP; Ariño J; Barceló A; Arús C
    Br J Cancer; 2012 May; 106(11):1816-25. PubMed ID: 22568967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma.
    Park J; Shim JK; Yoon SJ; Kim SH; Chang JH; Kang SG
    Sci Rep; 2019 Jul; 9(1):10555. PubMed ID: 31332251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
    Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
    Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
    Shilpi A; Kandpal M; Ji Y; Seagle BL; Shahabi S; Davuluri RV
    JCO Clin Cancer Inform; 2019 Apr; 3():1-9. PubMed ID: 31002564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simplified approach for the molecular classification of glioblastomas.
    Le Mercier M; Hastir D; Moles Lopez X; De Nève N; Maris C; Trepant AL; Rorive S; Decaestecker C; Salmon I
    PLoS One; 2012; 7(9):e45475. PubMed ID: 23029035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
    Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
    Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A robust two-gene signature for glioblastoma survival prediction.
    Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
    J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
    Fatai AA; Gamieldien J
    BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes.
    Orzan F; Pagani F; Cominelli M; Triggiani L; Calza S; De Bacco F; Medicina D; Balzarini P; Panciani PP; Liserre R; Buglione M; Fontanella MM; Medico E; Galli R; Isella C; Boccaccio C; Poliani PL;
    Lab Invest; 2020 Oct; 100(10):1330-1344. PubMed ID: 32404931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of glioblastoma (GBM) molecular classification methods.
    Lee E; Yong RL; Paddison P; Zhu J
    Semin Cancer Biol; 2018 Dec; 53():201-211. PubMed ID: 30031763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
    Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
    Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations.
    Teo WY; Sekar K; Seshachalam P; Shen J; Chow WY; Lau CC; Yang H; Park J; Kang SG; Li X; Nam DH; Hui KM
    Sci Rep; 2019 May; 9(1):7442. PubMed ID: 31092847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of T-cell exhaustion-related gene signature for predicting prognosis in glioblastoma multiforme.
    Liu YH; Jin HQ; Liu HP
    J Cell Mol Med; 2023 Nov; 27(22):3503-3513. PubMed ID: 37635346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
    Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
    J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-106a is an independent prognostic marker in patients with glioblastoma.
    Zhao S; Yang G; Mu Y; Han D; Shi C; Chen X; Deng Y; Zhang D; Wang L; Liu Y; Hou X; Wang C; Wu J; Liu H; Wang L; Zhang G; Qi J; Fang X; Shi C; Ai J
    Neuro Oncol; 2013 Jun; 15(6):707-17. PubMed ID: 23416698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.